Frequently asked questions
In 2022, the global Microplate Systems Market is expected to be worth USD 1.1 million.
The Microplate Systems Market is estimated to increase at a CAGR of 4.20% between 2023 and 2030, reaching USD 1.5Million in 2030.
The Pharmaceutical and Biotechnology Companies category is certainly the market leader in Microplate Systems.
The Monochromator-based Detection segment dominates the Microplate Systems Market.
The Absorbance Microplate Systems category has the highest CAGR in the Microplate Systems Market.
North America has the biggest market share in the Microplate Systems Market, accounting for roughly 40% of the entire market share in 2022.
The top players include Danaher Corporation, Biochrom, Lonza, Mindray., BERTHOLD, Promega Corporation, Agilent Technologies, BioTek, Rayto, PerkinElmer, Thermo Fisher Scientific, Tecan, BMG LABTECH, Corning, Bio-Rad, among others.
The key drivers of the market are the increasing requirement for high-throughput screening in drug development, technical developments in microplate systems, and an increase in the prevalence of chronic diseases, which are boosting the need for diagnostic testing.
High acquisition and maintenance costs, the difficulty of operating and maintaining microplate systems, and limited access for small and medium-sized laboratories with limited budgets all impede market growth.
Rising need for personalized medicine and targeted medicines, the inclusion of artificial intelligence and machine learning in microplate systems, and the rise of the biotechnology and pharmaceutical industries all contribute to the market’s substantial potential.